13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001387131-23-001890
Total Value
$255.0M
Positions
63
Other Managers
0
Confidential Omitted
No
Holdings (63)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CHINOOK THERAPEUTICS INC | 16961L106 | 818,035 | $21.4M | 8.41% |
| 2 | MADRIGAL PHARMACEUTICALS INC | MDGL | 70,000 | $20.3M | 7.97% |
| 3 | BRISTOL MYERS SQUIBB CO | CELG-RI | 175,000 | $12.6M | 4.94% |
| 4 | ESTABLISHMENT LABS HLDGS INC | ESTA | 190,767 | $12.5M | 4.91% |
| 5 | ASCENDIS PHARMA A S | ASND | 70,997 | $8.7M | 3.40% |
| 6 | BIOMARIN PHARMACEUTICAL INC | BMRN | 80,000 | $8.3M | 3.25% |
| 7 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 75,000 | $8.3M | 3.24% |
| 8 | VERONA PHARMA PLC | 925050106 | 312,498 | $8.2M | 3.20% |
| 9 | VENTYX BIOSCIENCES INC | 92332V107 | 240,623 | $7.9M | 3.09% |
| 10 | MORPHIC HLDG INC | 61775R105 | 280,921 | $7.5M | 2.95% |
| 11 | ARCELLX INC | ACLX | 240,143 | $7.4M | 2.92% |
| 12 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,143,531 | $7.2M | 2.81% |
| 13 | ASTRIA THERAPEUTICS INC | 04635X102 | 472,482 | $7.0M | 2.76% |
| 14 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 215,000 | $6.8M | 2.66% |
| 15 | INARI MED INC | 45332Y109 | 90,000 | $5.7M | 2.24% |
| 16 | MODERNA INC | MRNA | 30,000 | $5.4M | 2.11% |
| 17 | AMGEN INC | AMGN | 20,000 | $5.3M | 2.06% |
| 18 | HORIZON THERAPEUTICS PUB L | G46188101 | 45,000 | $5.1M | 2.01% |
| 19 | ROCKET PHARMACEUTICALS INC | RCKTW | 258,115 | $5.1M | 1.98% |
| 20 | CELLDEX THERAPEUTICS INC NEW | CLDX | 110,000 | $4.9M | 1.92% |
| 21 | BELLUS HEALTH INC NEW | 07987C204 | 573,678 | $4.7M | 1.85% |
| 22 | ASTRAZENECA PLC | AZN | 60,000 | $4.1M | 1.60% |
| 23 | CYTOKINETICS INC | CYTK | 87,601 | $4.0M | 1.57% |
| 24 | BRIDGEBIO PHARMA INC | BBIO | 10,000,000 | $3.9M | 1.53% |
| 25 | BRIDGEBIO PHARMA INC | BBIO | 7,500,000 | $3.4M | 1.34% |
| 26 | KURA ONCOLOGY INC | KURA | 268,747 | $3.3M | 1.31% |
| 27 | VIKING THERAPEUTICS INC | VKTX | 350,000 | $3.3M | 1.29% |
| 28 | LANTHEUS HLDGS INC | LNTH | 60,630 | $3.1M | 1.21% |
| 29 | VAXCYTE INC | PCVX | 60,000 | $2.9M | 1.13% |
| 30 | VERONA PHARMA PLC | 925050106 | 105,000 | $2.7M | 1.08% |
| 31 | GERON CORP | GERN | 1,056,500 | $2.6M | 1.00% |
| 32 | SYNDAX PHARMACEUTICALS INC | SNDX | 100,000 | $2.5M | 1.00% |
| 33 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 375,000 | $2.4M | 0.94% |
| 34 | VIKING THERAPEUTICS INC | VKTX | 250,000 | $2.4M | 0.92% |
| 35 | KARYOPHARM THERAPEUTICS INC | KPTI | 661,264 | $2.2M | 0.88% |
| 36 | COGENT BIOSCIENCES INC | COGT | 193,064 | $2.2M | 0.88% |
| 37 | POINT BIOPHARMA GLOBAL INC | 730541109 | 303,218 | $2.2M | 0.87% |
| 38 | NOVAVAX INC | NVAX | 200,000 | $2.1M | 0.81% |
| 39 | GERON CORP | GERN | 837,000 | $2.0M | 0.79% |
| 40 | XENON PHARMACEUTICALS INC | XENE | 50,000 | $2.0M | 0.77% |
| 41 | ARGENX SE | ARGX | 5,000 | $1.9M | 0.74% |
| 42 | NOVOCURE LTD | NVCR | 25,000 | $1.8M | 0.72% |
| 43 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 247,891 | $1.8M | 0.71% |
| 44 | VINCERX PHARMA INC | VNCE | 1,492,771 | $1.5M | 0.60% |
| 45 | PRECIGEN INC | PGEN | 1,500,000 | $1.5M | 0.58% |
| 46 | CENTESSA PHARMACEUTICALS PLC | CNTA | 460,328 | $1.4M | 0.56% |
| 47 | ESPERION THERAPEUTICS INC NE | ESPR | 2,500,000 | $1.4M | 0.53% |
| 48 | KALVISTA PHARMACEUTICALS INC | KALV | 188,292 | $1.3M | 0.50% |
| 49 | BIOATLA INC | BCAB | 150,000 | $1.2M | 0.49% |
| 50 | DYNE THERAPEUTICS INC | DYN | 92,170 | $1.1M | 0.42% |
| 51 | LIANBIO | LIANY | 650,000 | $1.1M | 0.42% |
| 52 | NURIX THERAPEUTICS INC | NRIX | 80,000 | $878,400 | 0.34% |
| 53 | MIRUM PHARMACEUTICALS INC | MIRM | 40,000 | $780,000 | 0.31% |
| 54 | FOGHORN THERAPEUTICS INC | FHTX | 109,991 | $701,743 | 0.28% |
| 55 | SEAGEN INC | SE | 5,000 | $642,550 | 0.25% |
| 56 | CONTEXT THERAPEUTICS INC | CNTX | 883,654 | $583,653 | 0.23% |
| 57 | INOZYME PHARMA INC | 45790W108 | 500,000 | $525,000 | 0.21% |
| 58 | NUVATION BIO INC | NUVB | 250,000 | $480,000 | 0.19% |
| 59 | IMMATICS N.V | IMTX | 187,204 | $469,882 | 0.18% |
| 60 | MILESTONE PHARMACEUTICALS IN | MIST | 100,000 | $396,000 | 0.16% |
| 61 | SCILEX HOLDING CO | SCLXW | 18,099 | $3,419 | 0.00% |
| 62 | MEDICUS SCIENCES ACQUISITION | G5960S124 | 33,333 | $2,933 | 0.00% |
| 63 | SCILEX HOLDING CO | SCLXW | 463 | $1,847 | 0.00% |